sb 203580 has been researched along with Leishmaniasis, American in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Awasthi, A; Boppana, R; Jain, N; Joshi, BN; Khan, A; Mathur, R; Mitra, D; Saha, B; Sawant, S | 1 |
1 other study(ies) available for sb 203580 and Leishmaniasis, American
Article | Year |
---|---|
CD40 signaling is impaired in L. major-infected macrophages and is rescued by a p38MAPK activator establishing a host-protective memory T cell response.
Topics: Animals; Anisomycin; CD40 Antigens; Cells, Cultured; Enzyme Activation; Enzyme Inhibitors; Gene Expression Regulation; Imidazoles; Leishmania major; Leishmaniasis, Cutaneous; Macrophages, Peritoneal; Mice; Mice, Inbred BALB C; Mitogen-Activated Protein Kinases; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; p38 Mitogen-Activated Protein Kinases; Protein Synthesis Inhibitors; Pyridines; Signal Transduction; Th1 Cells | 2003 |